Sekhar says to follow CDMO capex, not modality buzz like peptides and ADCs
An investor take on Indian contract manufacturers: the argument is that spending on plants for peptides, ADCs and oligos matters more than concall buzz.
Recap by typeshit. Post by Sekhar on X.